Page last updated: 2024-12-05
2-iodobenzenamine
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
2-iodobenzenamine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 11995 |
SCHEMBL ID | 74028 |
MeSH ID | M0550266 |
Synonyms (45)
Synonym |
---|
AC-1253 |
einecs 210-426-0 |
ai3-00493 |
nsc 34544 |
2-iodobenzenamine |
nsc34544 |
benzenamine, 2-iodo- |
nsc-34544 |
o-aminoiodobenzene |
aniline, 2-iodo- |
615-43-0 |
o-iodoaniline |
aniline, o-iodo- |
2-iodoaniline |
inchi=1/c6h6in/c7-5-3-1-2-4-6(5)8/h1-4h,8h |
2-iodoaniline, 98% |
I0046 |
AKOS000119174 |
A19769 |
o-iodoaniline; 1-amino-2-iodobenzene |
BBL011389 |
2-iodo-phenylamine |
F3284-8050 |
STL146491 |
FT-0601338 |
AM20040864 |
AH-034/32850056 |
2-iodo aniline |
SCHEMBL74028 |
PS-4064 |
2-iodaniline |
o-iodophenyl amine |
2-iodo-aniline |
DTXSID5060649 |
W-105136 |
mfcd00007680 |
benzenamine, iodo- |
J-802087 |
CS-W007318 |
2-iodoaniline, purum, >=98.0% (gc) |
SY005096 |
nsc34544nsc 34544 |
HY-W007318 |
EN300-19100 |
Z104472778 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (11)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 9 (81.82) | 24.3611 |
2020's | 2 (18.18) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.98
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.98) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 12 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |